Cost-reduction strategies for cardiac implantable electronic devices: Increased battery capacity and beyond.
作者信息
Bennett Matthew T
机构信息
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
出版信息
Heart Rhythm O2. 2024 Oct 9;5(11):762-763. doi: 10.1016/j.hroo.2024.10.001. eCollection 2024 Nov.
Abstract
摘要
相似文献
1
Cost-reduction strategies for cardiac implantable electronic devices: Increased battery capacity and beyond.心脏植入式电子设备的成本降低策略：提高电池容量及其他方面。
Heart Rhythm O2. 2024 Oct 9;5(11):762-763. doi: 10.1016/j.hroo.2024.10.001. eCollection 2024 Nov.
2
Projected longevities of cardiac implantable defibrillators: a retrospective analysis over the period 2007-17 and the impact of technological factors in determining longevity.植入式心脏除颤器的预计使用寿命：2007年至2017年期间的回顾性分析以及技术因素对确定使用寿命的影响。
Europace. 2020 Jan 1;22(1):149-155. doi: 10.1093/europace/euz222.
3
Effect of battery longevity on costs and health outcomes associated with cardiac implantable electronic devices: a Markov model-based Monte Carlo simulation.电池寿命对心脏植入式电子设备相关成本和健康结果的影响：基于马尔可夫模型的蒙特卡罗模拟
J Interv Card Electrophysiol. 2017 Nov;50(2):149-158. doi: 10.1007/s10840-017-0289-8. Epub 2017 Nov 6.
4
Battery life of cardiac implantable electronic devices explanted in funeral homes: a potential resource for underserved nations.在殡仪馆中取出的心脏植入式电子设备的电池寿命：为服务不足的国家提供的潜在资源。
Expert Rev Med Devices. 2022 Sep;19(9):733-737. doi: 10.1080/17434440.2022.2130757. Epub 2022 Oct 5.
5
Cardiac Implantable Electronic Miniaturized and Micro Devices.心脏植入式电子微型和微设备。
Micromachines (Basel). 2020 Sep 29;11(10):902. doi: 10.3390/mi11100902.
6
Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.具有心脏植入式电子设备和心力衰竭的患者，个性化的反应率编程可在 6 个月后提高运动耐量：一项 II 期研究。
Circulation. 2020 May 26;141(21):1693-1703. doi: 10.1161/CIRCULATIONAHA.119.045066. Epub 2020 Apr 17.
7
Factors of mortality in patients with cardiac implantable electronic device: 5-year experience.心脏植入式电子设备患者的死亡率因素：5 年经验。
Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20230998. doi: 10.1590/1806-9282.20230998. eCollection 2024.
8
[Management of patients with pacemakers or implantable cardioverter defibrillator undergoing radiotherapy].[接受放射治疗的起搏器或植入式心脏复律除颤器患者的管理]
Cancer Radiother. 2018 Oct;22(6-7):515-521. doi: 10.1016/j.canrad.2018.06.017. Epub 2018 Aug 25.
9
Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.心脏植入式电子设备患者的心血管磁共振成像：最佳实践和真实世界经验。
Europace. 2019 Aug 1;21(8):1220-1228. doi: 10.1093/europace/euz112.
10
Investigating the Cost-Effectiveness of Telemonitoring Patients With Cardiac Implantable Electronic Devices: Systematic Review.远程监测心脏植入式电子设备患者的成本效益研究：系统评价。
J Med Internet Res. 2024 Apr 19;26:e47616. doi: 10.2196/47616.
本文引用的文献
1
Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases.心血管植入电子设备感染及其预防、诊断和管理的最新进展：美国心脏协会的科学声明：得到国际心血管感染性疾病学会的认可。
Circulation. 2024 Jan 9;149(2):e201-e216. doi: 10.1161/CIR.0000000000001187. Epub 2023 Dec 4.
2
Pain during cardiac implantable electronic device implantation.心脏植入式电子设备植入过程中的疼痛。
Br J Cardiol. 2021 Oct 13;28(4):43. doi: 10.5837/bjc.2021.043. eCollection 2021.
3
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2019 年 HRS/EHRA/APHRS/LAHRS 对 2015 年最佳植入式心脏复律除颤器编程和测试专家共识声明的重点更新。
Heart Rhythm. 2020 Jan;17(1):e220-e228. doi: 10.1016/j.hrthm.2019.02.034. Epub 2019 May 15.
4
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.植入式心脏复律除颤器和心脏再同步治疗除颤器的电池寿命：技术、临床和经济方面。EHRA 的专家评论文章。
Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066.
5
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden.心脏再同步治疗除颤器电池寿命延长对瑞典的经济影响。
Clinicoecon Outcomes Res. 2016 Oct 31;8:657-666. doi: 10.2147/CEOR.S114921. eCollection 2016.
6
The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.植入式心脏再同步治疗除颤器中电池寿命的经济影响：医院和医疗保健系统的观点。
Europace. 2017 Aug 1;19(8):1349-1356. doi: 10.1093/europace/euw176.
7
Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.安培小时作为心脏再同步除颤器脉冲发生器电池寿命的预测指标：一项多中心研究。
Pacing Clin Electrophysiol. 2016 Jul;39(7):658-68. doi: 10.1111/pace.12831. Epub 2016 Mar 11.
8
Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.日常实践中的电池消耗及心脏复律除颤器寿命的中期预测：来自远程监测数据库的分析
Europace. 2016 Sep;18(9):1366-73. doi: 10.1093/europace/euv436. Epub 2016 Feb 3.
9
Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: A systematic review and meta-analysis.因美国食品药品监督管理局召回而进行的心脏植入式电子设备发生器预防性更换的并发症：一项系统评价和荟萃分析。
Heart Rhythm. 2015 Jul;12(7):1558-64. doi: 10.1016/j.hrthm.2015.04.003. Epub 2015 Apr 3.
10
Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.200909 例 Medicare 植入式心脏复律除颤器植入患者的感染率和相关因素：来自国家心血管数据注册中心的结果。
Circulation. 2014 Sep 23;130(13):1037-43. doi: 10.1161/CIRCULATIONAHA.114.009081. Epub 2014 Jul 31.
Zotero 插件